healthtech bpc 157 BPC-157 – Research Peptide FDA panel backs compounded BPC-157,

Cullen, R

According to the Mounjaro Summary of Product Characteristics (SmPC), these two treatments do not have a known direct pharmacological interaction, as they work through entirely different mechanisms and are metabolised via separate pathways

It reiterates the lack of human trials and long-term data

AOD 9604 is commonly used in in vitro adipocyte models, biochemical enzyme assays, and preclinical animal studies focused on metabolic research

Researchers who have mapped its activity describe GHK-Cu as a peptide that switches on a wide set of repair-related genes, which is part of why a supervised copper peptide protocol like GHK-Cu therapy is studied for both skin and scalp health